This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

"Anti-Aging" Formula Selling Like Hotcakes

NEW YORK, April 9, 2013 /PRNewswire/ -- If you've been trying in vain to find the new growth hormone-boosting formula everyone's been talking about, you can blame the popular media. The cutting-edge research behind the formula was recently featured on one of daytime television's hottest programs. This segment created a firestorm of demand for the proprietary amino acid compound developed by Sierra Research Labs™, and now the company is having to take steps to end the vast shortages the show created by issuing a new license for its revolutionary compound.

Initially, only two companies received rights to the formula: SanMedica International™, which sells it under the trade name SeroVital™-hgh to prestige retailer Ulta (and soon Neiman Marcus), and Limitless Worldwide™, which sells it as Thrive™-hGH in the direct-to-consumer market. Kerry Pack, a communications specialist with Sierra, tells us, "We were convinced that issuing two licenses to the compound would be more than enough to meet consumer demand, but with all the recent media coverage, sales have gone through the roof and our suppliers have been having trouble keeping up. So we're thrilled to announce that we've recently issued a third license to sports supplement company Novex Biotech®, which will sell the compound as Growth Factor-9™ exclusively at GNC, The Vitamin Shoppe, and Lucky Vitamin."

The media has been keeping human growth hormone (hGH) at the forefront of people's minds for months. It's been featured everywhere from CNN, The Dr. Oz Show, Fox News and The Today Show to Vanity Fair… SeroVital-hgh was even singled out in a feature editorial on HGH that appeared in a recent issue of Shape magazine. SeroVital has also been featured on Radar Online and New York Live, and makeup artists have been gushing about it in magazines like Star and OK!

hGH therapy has gone mainstream as the "it" treatment of celebrities and the uber rich thanks to its touted ability to reduce wrinkles, tighten saggy skin, boost energy, increase lean muscle mass, decrease body fat, recharge sex drive and make people look and feel decades — not years, but decades — younger.

And for years only the uber rich have been able to afford hGH, because the best way to increase hGH levels in the body was through prescription injections that can cost upwards of $1500 a month. But all that changed at the Obesity Society's most recent Annual Scientific Meeting, where a group of renowned scientists revealed that the highly specialized oral amino acid compound found in the Sierra formula has been clinically proven to increase mean, bioactive, serum (blood) growth hormone levels more than 600%.

Both the scientific community and the media are — understandably — extremely excited about this completely revolutionary discovery, and consumers are becoming desperate to get their hands on it. Sierra hopes that making the compound available through Novex Biotech at GNC, The Vitamin Shoppe and Lucky Vitamin in addition to the prestige and direct-to-consumer markets will help put an end to shortages and waiting lists. "This will give consumers an extra avenue to get their hands on our proprietary formula," Ms. Pack says. "Whether people purchase it as SeroVital-hgh, Thrive-hGH or Growth Factor-9, they can rest assured they're getting the precise, proprietary, patent-pending formula proven in the studies to increase mean growth hormone levels more than 600%."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,111.58 +4.88 0.03%
S&P 500 2,000.02 +2.10 0.11%
NASDAQ 4,570.6370 +13.29 0.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs